|
VWF
|
|
Change intervention group vs. placebo group
|
7
|
-0.27
|
−0.46, − 0.08
|
40.5
|
10.08
|
0.12
|
|
ICAM-1
|
|
Intervention group (after vs. before)
|
4
|
−0.19
|
− 0.45, 0.06
|
18.9
|
3.70
|
0.29
|
|
Placebo group (after vs. before)
|
4
|
3.51
|
1.28, 5.73
|
97.6
|
124.47
|
< 0.001
|
|
Change intervention group vs. placebo group
|
5
|
−1.96
|
−4.02, 0.09
|
97.4
|
153.96
|
< 0.001
|
|
VCAM-1
|
|
Intervention group (after vs. before)
|
6
|
−0.24
|
−0.44, −0.03
|
0.0
|
1.18
|
0.94
|
|
Placebo group (after vs. before)
|
6
|
−0.08
|
− 0.49, 0.33
|
76.5
|
21.32
|
0.001
|
|
Change intervention group vs. placebo group
|
7
|
−0.50
|
−1.19, 0.19
|
91.2
|
68.54
|
< 0.001
|
|
E-selectin
|
|
Intervention group (after vs. before)
|
8
|
−0.25
|
−0.41, − 0.08
|
0.0
|
6.15
|
0.52
|
|
Placebo group (after vs. before)
|
8
|
−0.10
|
−0.37, 0.17
|
66.0
|
20.56
|
0.004
|
|
Change intervention group vs. placebo group
|
10
|
−0.04
|
−0.36, 0.28
|
78.8
|
42.49
|
< 0.001
|
|
Endothelin
|
|
Intervention group (after vs. before)
|
4
|
−0.45
|
− 0.66, − 0.24
|
40.1
|
5.01
|
0.17
|
|
Placebo group (after vs. before)
|
4
|
0.11
|
−0.10, 0.31
|
0.0
|
2.98
|
0.39
|
|
Change intervention group vs. placebo group
|
4
|
−0.49
|
−1.18, 0.19
|
90.5
|
31.46
|
< 0.001
|
